Oxidative stress - Related spontaneous preterm delivery challenges in causality determination, prevention and novel strategies in reduction of the sequelae by Stefanovic, Vedran et al.
Accepted Manuscript
Oxidative stress - Related spontaneous preterm delivery challenges in causality
determination, prevention and novel strategies in reduction of the sequelae
Vedran Stefanovic, Sture Andersson, Maximo Vento
PII: S0891-5849(18)32495-X
DOI: https://doi.org/10.1016/j.freeradbiomed.2019.06.008
Reference: FRB 14307
To appear in: Free Radical Biology and Medicine
Received Date: 2 December 2018
Revised Date: 5 June 2019
Accepted Date: 6 June 2019
Please cite this article as: V. Stefanovic, S. Andersson, M. Vento, Oxidative stress - Related
spontaneous preterm delivery challenges in causality determination, prevention and novel strategies
in reduction of the sequelae, Free Radical Biology and Medicine (2019), doi: https://doi.org/10.1016/
j.freeradbiomed.2019.06.008.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 1 
Title: 
Oxidative stress - related spontaneous preterm delivery 
Challenges in causality determination, prevention and novel strategies in reduction of the sequelae 
Authors: 
Vedran Stefanovic1, Sture Andersson2, Maximo Vento3,4* 
Affiliations 
1 Department of Obstetrics and Gynecology, Fetomaternal Medical Center, Helsinki University and 
Helsinki University Hospital, Finland. 
2
 Children's Hospital, Pediatric Reserch Center, University of Helsinki and Helsinki University 
Hospital, Helsinki, Finland 
3Division of Neonatology; University and Polytechnic Hospital La Fe, Valencia, Spain. 
4Neonatal Research Group; Health Research Institute La Fe, Valencia, Spain. 
*Corresponding Author: 
Maximo Vento MD PhD; Health Research Institute La Fe; Division of Neonatology; University and 
Polytechnic Hospital La Fe; Avenida Fernando Abril Martorell 106; 46026 Valencia; Spain. 
Email address: Maximo.vento@uv.es  
Funding 
MV acknowledges PI17/0131 grant from the Instituto de Investigación Sanitaria Carlos III (Spanish 
Ministry of Science, Innovation and Universities) and RETICS funded by the PN 2018-2021 
(Spain), ISCIII- Sub-Directorate General for Research Assessment and Promotion and the European 
Regional Development Fund (FEDER), reference RD16/0022. 
VS acknowledges Helsinki University Hospital Research EVO Grants and Ms. Maaria Puupponen 
(University of Helsinki) for her technical assistance in the preparation of this manuscript. 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 2 
Key Words 
Prematurity, oxidative stress, biomarkers, amniotic fluid, placenta, amniocentesis, intrauterine 
inflammation, microbial invasion of the amniotic cavity 
Conflicts of Interest 
Authors declare no having conflicts of interest 
Abstract 
Spontaneous preterm birth (PTB) is one of the major complications of pregnancy and the main 
cause of neonatal mortality and morbidity. Despite the efforts devoted to the understanding of this 
obstetrical syndrome and improved medical care, there has been a tendency for the PTB rate to 
increase in the last decades globally. The costs of the screening for spontaneous PTB, its 
management, and treatment of the sequelae represent a major burden to the health service economy 
of high-income countries. In this scenario, it has been widely acknowledged that oxidative stress 
(OS) plays an important role in the pathogenicity of human disease in wide range of areas of 
medicine. There is an emerging evidence that an imbalance between pro-and-antioxidants may be 
associated with spontaneous PTB. However, there are still many controversies on the mechanisms 
by which OS are involved in the pathogenesis of prematurity. Moreover, the crucial question 
whether the OS is the cause or consequence of the disease is yet to be answered.  
The purpose of this article is to briefly summarize the current knowledge and controversies on 
oxidative stress–related spontaneous PTB and to give a critical approach on future perspectives on 
this topic as a classical example of translational medicine. Placenta-mediated pregnancy adverse 
outcome associated with OS leading to iatrogenic PTB (e.g. pre-eclampsia, intrauterine growth 
restriction, gestational diabetes) will not be discussed. 
Introduction 
Preterm birth, defined as birth before 37 gestational weeks is the leading cause of neonatal 
morbidity and mortality (1). Data from 184 countries showed that the global average PTB rate in 
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2010 was 11.1%, ranging from about 5% in northern Europe to 18% in subSaharian Africa (2). 
During the past few decades, the perinatal outcomes of preterm neonates have improved 
significantly; however, rates of spontaneous PTB have essentially remained constant despite some 
promissing interventions in its prevention (3). In high-income countries, the majority of PTBs occur 
spontaneously, either with intact membranes or preterm premature rupture of membranes (PPROM) 
(4). The costs of the screening for PTB, its management and treatment of the sequelae represent a 
major burden to the health service economies (1,2). 
Although PTB is a complex condition resulting from multiple etiologic factors, it is well accepted 
and documented that both infection and inflammation represent highly significant risk factors for 
PTB (3). However, despite the clinical and public health significance of PTB and recent research 
achievements, the correlation between infectious agents, molecular and immunological pathways 
and triggering factors for spontaneous PTB remain poorly understood reflecting the complexity of 
this obstetrical syndrome. It has been widely acknowledged that oxidative stress (OS) may play an 
important role in the pathogenesis of human disease and constitutes a major topic in all areas of 
medicine (5). In this regard, there is emerging evidence that an imbalance between oxidants and 
antioxidants may be associated with PTB (6). Table 1 lists recent interventional studies aiming to 
reduce the incidence/severity of oxidative stress in preterm birth.  
Oxidative stress, antioxidants and oxidative damage biomarkers 
Oxidative stress 
Oxygen is the final acceptor of electrons generated during cellular metabolic activity which imply 
mainly the oxidases’activity (xanthine oxido-reductase; NADPH oxidases), nitric oxide synthase 
(NOS), and the mitochondrial oxidative phosphorylation. Under physiologic conditions, di-oxygen 
undergoes a tetravalent reduction and combined with 2 protons will produce water, a neutral 
element. However, under pathologic conditions oxygen may be incompletely reduced to form 
reactive oxygen species (ROS). Monovalent reduction, is the most common incomplete reduction 
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and results in the generation of anion superoxide (•O2-). Further reduction with 2 or 3 electrons 
leads to the formation of hydrogen peroxide (H2O2) and hydroxyl radical (•OH), respectively the 
latter being highly reactive. In addition, nitric oxide (NO•) may combine with ROS especially anion 
superoxide to conform peroxynitrite (ONOO−) a reactive nitrogen species (RNS). ROS and RNS 
may behave as free radicals which are highly reactive species with an extremely short half-life and 
with great affinity for electrons of nearby molecules.  Free radicals react with proteins, DNA, RNA, 
glucids or free fatty acids causing alteration of both their structure and function, begetting them as 
free radicals and triggering chain reactions (7,8,9). H2O2 is a ROS but not a free radical and acts as 
a cell-signaling molecule that regulates the redox-mediated oxidation of cysteine residues within 
proteins and plays, therefore an important role in intracellular antioxidant defense and the redox 
regulation code (10).  
Oxidative stress is broadly referred to as an imbalance between the generation of ROS and RNS and 
their clearance by the antioxidant defense system in favor of the former (8). ROS are generated in 
different intracellular compartments, such as the plasma membrane, the peroxisomes, the 
endoplasmic reticulum, and in the cytosol. The main endogenous source of ROS is the 
mitochondrial electron transport chain during respiration, being the rate of ROS production 
proportional to the rate of mitochondrial respiration. In addition, free circulating transition metals 
(Fenton chemistry) and enzymes that catalyze ROS-generating chemical reactions, such as 
peroxidases, NADPH oxidase, xanthine oxidase, lipoxygenases, myeloperoxidase, nitric oxide 
synthase, and cyclooxygenases, are also relevant sources of ROS. However, there are circumstances 
such as infection, radiation, or inflammation in which other subcellular structures such as 
peroxisomes, Golgi apparatus, or endoplasmic reticulum become sources of ROS that outweigh the 
mitochondria (8).  
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Antioxidant defenses 
The redox balance of the different cellular compartments is tightly regulated by the enzymatic and 
non-enzymatic antioxidant defense systems.  Antioxidants can directly reduce free radical and 
attenuate their reactivity, modify their chemical structure to neutral species, quench damage caused 
by free radical chain reactions or sequester transition metals to avoid Fenton chemistry (11). 
According to their characteristics there are low molecular weight antioxidants such as glutathione 
(GSH), vitamins C and E, or circulating bilirubin or uric acid among others. These compounds are 
electron donors that reduce free radicals attenuating their reactivity. In addition, there are enzymatic 
antioxidants that neutralize free radicals. The most relevant are the group of superoxides 
dismutases, catalase, glutathione redox cycle enzymes, DT diaphorase, and the peroxiredoxin. 
Finally, high molecular non-enzymatic proteins (thioredoxin, glutaredoxin, and metalothioneins) 
that have different antioxidant properties such as sequestering transition metals to avoid Fenton 
chemistry, or act as electron donors, or physically quench chain reactions (12).  In a pro-oxidant 
situation, non-enzymatic antioxidants constitute the first barrier of defense directly reducing or 
quenching free radicals.  Simultaneously, there is an activation of a coordinate array of antioxidant 
defenses including nuclear factor (erythroid -derived)-related factors (NrFs) family of transcription 
factors. Among these, NrF2 is the mos relevant and is involved in a wide range of signal 
transduction pathways that deal with oxidative stimulation (13). Under stressful conditions, NrF2 
translocates to the nucleus where it activates the antioxidant responsive element (ARE) gene 
expression.  As a consequence, an array of antioxidant enzymes will be expressed that will 
neutralize free radicals and balance the oxidant status that leads to the promoting cell survival (14). 
NrF2 target genes have multiple biological functions such as being responsible for detoxification 
(NQ01, GSTs, AKRs) and the activation of specific antioxidant enzymes such as glutathione 
peroxidase, glutamate-cysteine ligase, glutamate-cysteine ligase modifier subunit, glutathione 
reductase, superoxide dismutases family, thioredoxin and peroxiredoxins (15). Under physiologic 
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conditions, antioxidant response maintains low concentrations of ROS and RNS which act as 
regulatory mediators in signaling processes. However, at moderate or high concentrations, they act 
as free radicals altering cellular function and the redox status indispensable for cell reproduction, 
growth, and differentiation (16).  
Oxidative stress and damage biomarkers 
The extremely short half life of free radicals doesn’t allow to directly measure their concentration in 
the clinical setting. Therefore, different analytical strategies have been employed to assess the 
oxidant status. Hence, extracellular (plasma, serum, urine, amniotic fluid, cerebral spinal fluid) or 
intracellular (erythrocytes, leukocytes) compartments oxidant status has been performed 
determining the reduced to oxidized quotient of molecules containing sulfur-disulfide bonds such as 
reduced to oxidized glutathione (GSH/GSSG), cysteine-cystine (Cys-H/Cys-SS) or reduced to 
oxidized thioredoxin (Trx-SH/Trx-SS) or the activity of enzymatic antioxidants such as SOD, CAT 
or GPX (12,17).  Recently, our lab has developed a new method based on surface enhanced Raman 
spectroscopy (SERS) to easily analyze GSH.We have performed analytical monitoring with high 
reliability by using a silver colloid that enhances the GSH signal and allows for the accurate 
measurement of microvolumes (20 mcl) of blood. This novel analytical tool has been validated and 
is extremely suitable, using portable optical sensor device to perform point-of-care (POC) testing of 
OS levels in newborns (18).   
Increasingly, the use of highly precise analytical platforms such as high-performance liquid or gas 
chromatography coupled to mass spectrometry has allowed to determine an array of byproducts 
resulting from the oxidative damage to specific tissue components such as protein, lipids, 
carbohydrates or nucleic acids measured in different biofluids are used as surrogates for oxidative 
stress (17). 
Free radicals provoke oxidative modifications of the chemical structure of proteins such as 
oxidation of sulfur residues to sulfide, hydroxylation of aromatic groups, nitration or chlorination of 
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tyrosine residues, or conversion to carbonyl derivatives. Among the most widely employed 
biomarkers are related with the oxidation of Phenyalanine (Phe).  Hydroxyl radicals convert Phe to 
ortho-tyrosine (o-Tyr) or meta-tyrosine (m-Tyr), peroxynitrite leads the formation of 3-nitrotyrosine 
(3NO2-Tyr) and hypochlorous acid to 3-chlorotyrosine (3Cl-Tyr), the latter ones relative to protein 
nitration and inflammation (19). 
Intrauterine infection, inflammation and oxidative stress in preterm birth etiology 
Intrauterine infection and inflammation are the leading etiological factors in the pathogenesis of 
spontaneous PTB (20) and risk factors for brain damage in the neonate, especially in those born 
very prematurely (21). Pro-inflammatory stimuli, such as lipopolysaccharide (LPS) and other 
bacterial, viral or fungal byproducts often recognized by the toll-like receptor (TLR) pathways, or 
intercellular signaling mediators often recognized as members of the TNF-α superfamily or 
immunoglobulin domain-containing receptors are strong inducers of NK-kB activity in many cell 
types including placenta. NFkB is responsible for activating its target genes involved in multiple 
cellular processes, including inflammation, survival, proliferation, differentiation, apoptosis or cell 
cycle arrest. Once activated, NF-kB translocates into the nucleus to activate the expression of an 
ample array of genes that constitute the inflammatory response (22, 23).   Hence, genes encoding 
inflammatory mediators that control cell activation and chemotaxis, such as the proinflammatory 
cytokines TNF-alpha, IL-1 and IL-12, chemokines such as monocyte chemotactic protein (MCP)-1, 
interferon (IFN)-inducible protein (IP)-10 and RANTES.  In addition, large numbers of NF-kB 
dependent genes contribute to the innate immune response, anti-microbial peptide beta-defensin-2 
or C-reactive protein (22, 23).  
Intrauterine infection and inflammation cause an increased production of proinflammatory 
cytokines in the fetal brain that triggers the activation of microglia with the consequent release of 
free radicals that inevitably cause injury to oligodendrocytes and neurons in the most critical stage 
of fetal brain development (24, 25).  
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In experimental studies in different mammal species, the antioxidant enzyme (AO) levels are not 
sufficiently efficient to overcome fetal to neonatal transition until late in gestation (26). Hence, 
during the final 10–15% of gestation, there is an exponential increase of 150–200% activity in the 
AO enzymes present in lung tissue. (27). Consequently, preterm infants with an immature AO 
enzyme system will be predisposed to oxidative stress-associated lung damage and respiratory 
insufficiency (28). Notably, the use of antenatal steroids increases the AO enzyme activity, 
especially in preterm females improving their ability to satisfactorily transit into the extra uterine 
world (29). 
Little is known about OS in the human fetus and most of the published data are based on results 
obtained in animal models. However, in type 1 diabetes or insulin-treated gestational diabetes the 
association of chronic fetal hypoxia with OS has been recently studied using high performance 
liquid chromatography coupled to quadrupole mass spectrometry (HPLC-MS/MS) after validating a 
specific method for the determination of markers of oxidative damage to proteins (meta-
tyrosine/phenylalanine ratio) and DNA (8-oxo-dihydroguanosine/2-dihydoguanosine ratio), and 
nitrosative stress (3-NO-tyrosine) in amniotic fluid.   Results clearly established a correlation 
between amniotic fluid markers of oxidative and nitrosative stress and erythropoietin an indirect 
marker of fetal hypoxia (30). Moreover, fetus with hypoxic events in utero and poor postnatal 
adaptation evidenced by low Apgar score and metabolic acidosis exhibited higher concentrations of 
lipid peroxidation biomarkers in cord blood, specifically 8-iso-15 (R)-PGF2α and total isoprostanes 
than normal controls (31). 
Buhimschi et al demonstrated that term labor triggers a compensatory up-regulation of 
nonenzymatic antioxidant reserve in the fetal red blood cell and plasma compartments which serves 
as a protective mechanism to the relative postnatal hyperoxia (32). Conversely, the decreased 
nonenzymatic antioxidant reserve after preterm labor and delivery would enhance the vulnerability 
to free radical damage of the preterm neonate. Authors speculate that the two compartments of 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9 
nonenzymatic antioxidant reserve have distinct defensive roles in the perinatal period. Oxidative 
stress is linked to both infection and inflammation and may contribute to the perinatal brain damage 
in premature infants (33).  Mass spectrometry methods to study intraamniotic fluid infection (IAA) 
have been recently validated following the stringent FDA requirements (34, 35). These methods 
have allowed to approach with high accuracy and reliability the influence of oxidative stress and 
inflammation in the clinical setting (34, 35).  Spontaneous PTB may occur with intact membranes 
or after premature preterm rupture of membranes (PPROM) with different latency. Athough it has 
been proposed that the etiology of PTB with intact membranes differs from that with PPROM (36, 
37, 38), it has been demonstrated by amniocentesis that IAI and microbial invasion of the amniotic 
cavity share the similar pattern in both entities (39, 40). The common finding of these studies is that 
the proportion of samples demonstrating severe inflammation and/or microbial invasion of the 
amniotic cavity is much higher in pregnancies with lower gestational age, especially before 25 
weeks. Furthermore, not only the presence, but the magnitude of IAI was much higer in amniotic 
fluid samples from lower gestational ages than later on.  These findings may ultimately question the 
results of meta-analyses on antibiotic use in women with preterm labour with intact membranes. 
Meta–analysis of 11 included trials showed a reduction in maternal infection with the use of 
prophylactic antibiotics but failed to demonstrate benefit or harm for any of the pre–specified 
neonatal outcomes (41). Additionally, there was a suggestion of harm with almost significant 
increase in neonatal mortality in the antibiotic group. These trials included 7428 women, but 
amniocentesis was not performed in any of them. By combining histological diagnosis of 
chorioamnionitis with quantitative brain MRI, Anblagan et al have recently shown that 
inflammation in utero contributes to altered microstructure in major white matter tracts of preterm 
infants at term equivalent age (42). Chorioamnionitis is a well-known risk factor for fetal and 
neonatal infection as up to 17% of preterm newborns whose mother has chorioamnionitis develop 
EOS in both PTL and PPROM (43). 
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Placental histopathology may have a role in risk stratification for trials of immune-modulatory 
therapies designed to improve outcome (43). However, it has been demonstrated that twenty-four 
percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either 
culture-proven intraamniotic infection or IAI, and false-positive diagnosis of clinical 
chorioamnionitis in preterm gestation may lead to unwarranted preterm delivery. (44).  
Amniocentesis and placental investigations-evidence for inflammation, infection and oxidative 
stress-related preterm birth. 
Amniocentesis is a safe and feasible procedure that should be performed in selected cases of 
patients with threatened PTB either with intact membranes or PPROM (45,46,47,48). The 
information about the status of intrauterine environment (regardless of determination the microbial 
invasion of the amniotic cavity (MIAC), inflammation and/or oxidative stress) obtained by 
amniocentesis outweigh its potential risks and costs. These results may properly identify women 
that would not benefit of certain obstetrical procedures (emergency cerclage, tocolysis) and those 
that would deliver within a very short interval after amniocentesis (49, 50). This would allow better 
timing of antenatal steroids for lung maturation, magnesium sulfate for neuroprotection, and 
optimal antibiotic administration in case of MIAC. Also, the results of amniocentesis would help to 
restrain from unnecessary and potentially harming procedures as mentioned above. Although, 
taking into consideration that IAI is present in approximately 14% of women with PTB (with or 
without PPROM), not all women would need this procedure; however, the non-invasive 
stratification of the at-risk patients has not been successful so far (51). Although it seems that 
antibiotic administration rarely eradicates the IAI in women with PPROM.  There is an evidence of 
a sub-group of patients with documented inflammation of the amniotic cavity which demonstrated a 
decrease in the intensity of the inflammatory process after antibiotic administration (52). Currently, 
preterm labor is unfortunately too often considered as irreversible in the setting of an infection. This 
nihilistic view should be challenged due to several reasons:  infection-induced preterm labor in the 
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non-human primate model was significantly delayed by anti-inflammatory and antibiotic 
administration, and recent data suggest that rapid identification of intra-amniotic infection and 
inflammation is possible (52,53,54). 
Amniotic fluid and placental oxidative stress markers in pregnancies with preterm labor with 
intact membranes and/or PPROM. 
Isoprostanes (F(2)-IP) are produced by ROS attack on polyunsaturated fatty acids and are sensitive 
and specific biomarkers of lipid-peroxidation in vivo in adults and neonates (9,12,55,56). Dutta et 
al., have studied concentration of F2-Isoprostane as biomarkers of OS in amniotic fluid samples 
from pregnancies with PPROM and PTB with intact membranes, demonstrating a 3-fold increase in 
F2-Isoprostanes in PPROM suggesting that OS-associated damage is more pronounced in PPROM 
than in PTB (57). In the same line of research, Kwiatkowski et al hypothesized that isoprostanes 
would be good markers of premature rupture of membranes. For this purpose, they determined 8-
iPF2(2α)-III isoprostanes and showed that levels of this specific isoprostane were significantly 
higher in term infants with intact membranes as compared to preterm or term infants with PPROM. 
Hence, levels of iPF2(2α)-III in maternal plasma and amniotic fluid can be considered reliable 
markers of pregnancy at risk of preterm rupture of membranes (58). Studies by Longini et al., have 
also shown that women with PPROM had higher level of F2-isoprostane in the amniotic fluid at the 
time of genetic amniocentesis between 15-18 gestational weeks than those with term delivery (59). 
Biomarkers derived from oxidative damage to DNA such as 8-hydroxy-2 deoxy-dihydroguanosin 
are also increased in pregnancies with chorioamnionitis (60). Polycyclic aromatic hydrocarbons 
(PAH) alter the antioxidant defense system and as a consequence provoke an induction of early 
delivery. In a study performed by Agarwal et al., placenta tissue samples were obtained from 
healthy pregnant women and levels of PAHs quantified.  Oxidative stress was assessed by 
determining malondialdehyde and reduced glutathione in placental tissue. Increased benzo(a)pyrene 
and MDA and decreasing concentrations of GSH were found in women with preterm delivery as 
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compared to term controls.  In addition, higher and lower molecular weight PAHs showed 
significant correlation with the tendency towards depletion of GSH showing that oxidative stress 
and a pro-oxidant redox status caused by PAH may contribute to preterm delivery (61).  
Perrone et al., reported that placentas with histological lesions compatible with chorioamnionitis 
and inflammation in preterm pregnancies were associated with higher cord  blood levels of F2-
isoprostanes (62). 
A body of evidence has revealed that spontaneous preterm labour with or without PPROM may be 
triggered by premature placental ageing caused by OS‐induced damage, premature senescence of 
the fetal membranes and telomere reduction (surrogate for OS) (63,64,65). Soydinc et al 
demonstrated that in non-invasively obtained vaginal washing fluid, levels of markers of total 
oxidative stress were significantly higher in women with PPROM than in those with intact 
membranes (66). Furthermore, higher level of oxidative stress and lower level of anti-oxidant 
capacity markers were observed in women with PPROM with consequent histological 
chorioamnionitis as compared with PPROM but without chorioamnionitis. Özalkaya et al 
demonstrated that umbilical cord pro-oxidant TOS level was higher in preterm infants without fetal 
inflammatory response syndrome (FIRS) and with PPROM compared to those without FIRS and 
PPROM (67). 
 
Interventions to reduce oxidative stress in preterm birth 
1.Antenatal steroids 
Antenatal steroid (AS) administration has been a part of routine protocol of the PTB management 
between 24 and 34 weeks of gestation for many decades. It has been shown indisputably that the 
effectiveness AS administration to the mother within 7 days before delivery significantly reduces 
not only the incidence and severity of respiratory distress syndrome, but also other prematurity 
related problems such as bronchopulmonary dysplasia, patent ductus arteriosus, intracranial 
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hemorrhage, retinopathy of prematurity and necrotizing enterocolitis. Free radical production and 
oxidative stress are associated with all of these neonatal conditions. Vento et al., showed that the 
maximal effect of AS was achieved when administered 2–4 days before delivery (29). Moreover, 
this study also showed an association between antenatal steroids and activities of antioxidant 
enzymes and glutathione cycle enzymes in cord blood. Accordingly, extremely preterm infants who 
received antenatal steroids exhibited decreased levels of biomarkers of oxidative damage to proteins 
(O-tyrosine) and DNA (8-oxodG) (29). Unfortunately, there is an evidence of an inappropriate 
timing of the AS administration. Sanya et al., demonstrated that over two-thirds of the women 
presenting suspicion of PTB delivery after 34 weeks of gestation received AS unnecessarily (68, 
51). Furthermore, in large cohorts of women who delivered before 34 weeks of gestation, AS was 
administered within 7 days of delivery only in approximately 40% of cases (69, 52). Despite these 
inconveniences, epidemiological studies confirm that more than 80% of preterm infants born in 
industrialized countries receive at least one dose of AS before being born (70). 
2. Magnesium sulfate fetal neuroprotection 
Summarizing the results of five randomized control trials, a meta-analysis published in 2009 
demonstrated that magnesium sulphate given to mothers shortly before delivery reduced the risk of 
cerebral palsy by 32% and improved gross motor function in preterm infants born before 32 weeks 
of gestation without side effects for the mother or long-term consequences for the newborn (71). 
Based on high quality evidence of benefit, MgSO4 is currently recommended worldwide for women 
at risk of preterm birth before 32 weeks of gestation for fetal neuroprotection. The number of 
women needed to be treated to benefit one baby by avoiding cerebral palsy is 63. There is still a 
lack of understanding of the MgS04 neuroprotective mechanisms. Magnesium is an important 
cation that regulates cellular calcium influx regulating voltage-gated Ca++ channels and as a 
consequence cerebral vascular tone thus protecting fetal brain (72). Moreover, under stressful 
situations blocking massive entrance of Ca++ reduces the activation of the Krebs’ cycle and the 
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liberation of highly energized electrons that lead to a burst of oxygen free radicals in the 
mitochondria (72). Additionally, it has been demonstrated in animal models that MgSO4 decreases 
the production of free radicals during hypoxic-ischemic reperfusion (73). Cerebral vasodilatation 
and reduction in inflammatory cytokine production have been reported (74,75). This theory is 
supported in a randomized controlled trial that included 72 women and showed increased levels of 
brain-derived neurotrophic factor (BDNF) in cord blood from pregnancies with MgSO4 
neuroprotection administered before 34 weeks of gestation compared with placebo (76). There is 
evidence that BDNF is protective against neonatal hypoxic-ischaemic brain injury in vivo (77). 
Thordstein et al demonstrated that a combination of oxygen radical scavengers and magnesium 
administered in the phase of resuscitation mitigates perinatal postasphyxial brain damage in the rat 
(78).  
3.Anti-inflammatory medication 
Free radicals are generated in large quantities during the inflammatory response shifting the 
fetomaternal redox balance to a pro-oxidative state compromising the fetus.  Selective inactivation 
of free radicals with N-acetylcysteine (NAC), both an antioxidant and L-cysteine donor for the 
synthesis of reduced glutathione (GSH), seems an effective way of improving fetal outcome in 
preterm deliveries associated with inflammation.  In experimental studies, NAC administration to 
pregnant rats significantly reduced oxidized glutathione (GSSG) in isolated hepatocytes that 
occurred in the fetal-neonatal transition. The GSH/GSSG ratio in liver of NAC-treated newborns 
was 411 +/- 216 and in liver of controls it was 283 +/- 176. Thus, the oxidative stress in the fetal-to-
neonatal transition was significantly reduced by oral NAC administration to pregnant rats (79). 
Buhimschi et al., demonstrated in a mice model of preterm labor and fetal damage that maternal 
inflammation in C57Bl/6 mice caused fetal oxidative stress and death, and was associated with 
maternal and fetal GSH depletion (79). Moreover, they also showed also that oxidative stress 
caused damage to the fetus independently of prematurity and that restoration of maternal and fetal 
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oxidative balance by NAC protected the fetus and reduced the rate of preterm birth (80). Buhimshi 
et al., in another study collected fetal membranes from 7 patients undergoing elective cesarean 
delivery at term and demonstrated that NAC dramatically inhibited amniochorionic matrix 
metalloproteinase activity in addition to inhibiting intrinsic superoxide generation within the tissue 
(81). In a randomized, double-blind, placebo-controlled trial including 280 women that had 
previously have given birth prematurely, showed that oral NAC reduced the recurrence of preterm 
birth in patients with bacterial vaginosis (82). The safety and possible pharmacodynamics side 
effects of NAC were investigated in a randomized, controlled pilot trial that included 22 pregnant 
women at ≥24 weeks gestation within 4 hours of clinical diagnosis of chorioamnionitis and their 
infants concluding that antenatal and postnatal NAC was safe, preserved cerebrovascular regulation, 
and increased an anti-inflammatory neuroprotective protein (83). 
4. Antibiotics and intra-amniotic inflammation 
Molecular microbiology techniques have evidenced the presence of a great diversity of different 
microbes in the amniotic fluid in pregnancies with PTB with intact membranes or PPROM.  
Morimoto et al., demonstrated that broad-range PCR-based approach is more useful for identifying 
women with IAI as well as women with polymicrobial infection than the culture-based approach is 
(84). They also found a correlation between the abundance of 16S rDNA and the severity of IAI 
(84). It is generally accepted that most IAIs result from a chronic bacterial infection and that the 
overt symptoms and neonatal outcome depend not only on the bacterial load but also in the 
presence, duration, and magnitude of the inflammation secondary to the infection (85). 
Azithromycin was introduced as an empirical antibiotic treatment for all women with PPROM in 
Helsinki University Hospital based on our research and the current literature that describes the 
bacteria specia detected from amniotic fluid in PPROM women (86). Azithromycin covers, among 
other bacteria, genital mycoplasmas, ureaplasmas and Fusobacterium nucleatum. This antibiotic 
exhibits potent anti-inflammatory effects mediated by the inhibition of IL-1β-mediated 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 16
inflammation produced by the inflammasome and simultaneous regulation of the NF-kB activity in 
response to oxidative stress and lipopolysaccharides rendering extreme useful in the control of 
chronic lung inflammation (87). The possible application of azithromycin for inflammatory 
processes such as chorioamnionitis in the perinatal period deserves further studies.  
5. Progesterone 
Experimental studies demonstrated that progesterone receptor membrane component I (PGRMCI) 
can be regulated by progestins, inflammatory cytokines, and oxidative stress in the fetal membranes 
and also that PGRMCI acts as a protective element for maintaining fetal membrane integrity by 
inhibiting oxidative stress-induced chorion cell ageing (88,89).  Recent clinical evidence has 
demonstrated the benefit of administering progesterone and its analogues as prophylaxis for 
spontaneous PTB in high-risk patients. The mechanism by which vaginal P4 decreases the risk for 
PTB appears to be related to the pathophysiology of cervical remodeling during the prelude to 
parturition. Systematic review and meta-analysis of individual patient data of randomized controlled 
trials comparing vaginal progesterone with placebo/no treatment in women with a singleton 
gestation and a midtrimester sonographic cervical length  ≤25 mm showed that vaginal 
progesterone decreases the risk of preterm birth and improves perinatal outcomes without any 
demonstrable deleterious effects on childhood neurodevelopment (90).As an example, the number 
needed to treat to prevent one preterm birth  ≤ 32 weeks of gestation  is six  (90). 
Conclusions 
Spontaneous preterm birth is one of the major complications of pregnancy and the main cause of 
neonatal mortality and morbidity (1). In survivors, this risk persists through the adulthood causing 
both medical and social disability and is increased with decreasing gestational age at birth (91). 
There is  accumulated evidence that correlates OS to PTB regardless of the fetal membrane status. 
Whether OS is a trigger for PTB or its consequence yet remains to be elucidated. Hence, the 
standardization and clinical evaluation of different markers of OS in should be integrated in the 
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management protocols of PTB. Strategies to prevent PTB-related OS should include preventive 
antioxidant administration to women with a high-risk for PTB (including progesterone treatment for 
women with high-risk for PTB), administration of appropriate antibiotics with proven microbial 
invasion of the amniotic cavity, and the introduction of anti-inflammatory agents for patients with 
proven inflammation aiming to reduce oxidative stress and prolong the latency period between PTB 
clinical signs and after PPROM. Appropriate administration of antenatal steroids and magnesium 
sulphate for fetal neuroprotection should be a standard of care in every obstetrical unit. All these 
therapies have minimal or no side-effects to fetus, newborn and pregnant women if administered 
according to the guidelines. However, these strategies show evidence of short-term benefit but lack 
large-scale follow-up data of long-term childhood outcomes (92). We expect that future research on 
preterm birth interventions should include long-term follow-up of the children to address the 
optimal strategies for the prevention and reducing the sequelae.  
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Graphical abstract. Scheme representing the simplified list of interventions to avoid or attenuate 
oxidative stress in preterm delivery. PTL= preterm delivery; PPROM= preterm premature rupture 
of membranes. MIAC= microbial invasion amniotic cavity. 
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Table 1. Published studies describing intervention strategies to prevent preterm birth and its sequelae by decreasing oxidative-stress and 
inflammation  
 
Intervention/issue 
studied 
Type of the study Sample and methods Main findings Conclusion References 
Antenatal steroids for 
lung maturation 
Prospective 
observational-
cohort clinical 
study 
Extremely low-
gestational-age 
neonates (>28 weeks of 
gestation) receiving 
antenatal steroids 
(CORT, n= 37) or not 
(NOCORT, n=20)  
There is an association between antenatal steroids  
and activities of antioxidant enzymes and  
glutathione cycle enzymes in cord blood.  
In addition, reduced oxidative stress,  
and decreased oxidation of proteins and DNA  
was also demonstrated 
 
Antenatal administration of steroids reduces 
oxidative stress and decreases the intensity of 
prematurity sequelae (oxygen supplementation, 
mechanical ventilation, and conditions such as 
bronchopulmonary dysplasia, intra-
periventricular hemorrhage, or retinopathy) 
related to free-radical production and oxidative 
stress 
Vento et al 
(2009) 
 
Reference #29 
Magnesium sulfate 
(MgS04) for fetal 
neuroprotection 
Randomized 
controlled clinical 
trial 
72 pregnant women 
who were divided into 
three groups: group I 
(preterm pregnancy 
with MgSO4), group II 
(preterm pregnancy 
without MgSO4), and 
group III (full-term 
pregnancy as control 
group) 
The cord blood brain-derived neurotrophic factor 
(BDNF) levels in premature infants with antenatal 
MgSO4 was significantly higher than in 
premature infants without antenatal MgSO4 and 
was comparable to full-term infants 
The application of antenatal MgSO4 in preterm 
delivery increased cord blood BDNF levels, 
which downregulation increases sensitivity to 
oxidative damage under stressful circumstances 
Bachnas et al 
(2014) 
 
Reference #76 
N-Acetyl-Cysteine 
(NAC) for prevention 
of recurrent preterm 
birth in adjunct to 
progesterone 
A randomized, 
double-blind, 
placebo-
controlled trial 
280 women between 16 
and 18 weeks of 
pregnancy who had 1 
previous preterm birth 
and had just been 
successfully treated for 
bacterial vaginosis with 
metronidazole for 1 
week. The women 
were randomized to 
receive 0.6 g of NAC 
per day plus 17-
hydroxyprogesterone 
caproate (17-OHPC) or 
placebo plus 17-OHPC 
until 36 completed 
weeks of pregnancy or 
active labor. 
Reaching 36 weeks of pregnancy was more 
frequent and gestational age at delivery was 
significantly higher in the NAC than in the 
placebo group (37.4 weeks ± 0.4 weeks vs 34.1 
weeks ± 1.2 weeks) 
Oral NAC (known to be powerful anti-oxidant) 
was found to reduce the recurrence of preterm 
birth in patients with bacterial vaginosis 
Shahin et al 
(2009) 
 
Reference #82 
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Antenatal and postnatal 
NAC treatment of 
newborns exposed to 
chorioamnionitis 
Randomized, 
controlled, 
double-blinded 
trial 
22 pregnant women  
(24 infants)  >24 weeks 
of gestation presenting 
within 4 hours of 
diagnosis of clinical 
chorioamnionitis were 
randomized to NAC or 
saline treatment. 
Antenatal NAC or 
saline was given 
intravenously every 6 
hours until delivery. 
Postnatally, NAC or 
saline was given every 
12 hours for 5 doses 
Cerebrovascular coupling was disrupted in infants 
with chorioamnionitis 
treated with saline but preserved in infants treated 
with NAC, suggesting improved vascular 
regulation in the presence of neuroinflammation. 
Infants treated with NAC had higher serum anti-
inflammatory interleukin-1 receptor 
antagonist and lower proinflammatory vascular 
endothelial growth factor over time vs controls. 
In this cohort of newborns exposed to 
chorioamnionitis, antenatal and postnatal NAC 
was safe, preserved cerebrovascular regulation, 
and increased an anti-inflammatory 
neuroprotective protein 
Jenkinks et al 
(2016) 
 
Reference #83 
Oxidative stress 
influence  on 
Progesterone  receptor 
membrane component I 
(PGRMCI) in fetal 
membranes 
Experimental 
study 
Human fetal 
membranes collected 
following planned 
uncomplicated 
cesarean delivery at 
term without rupture of 
membranes or labor. 
The objective was to 
evaluate progesterone 
receptor membrane 
component I 
(PGRMCI) expression 
in cells of the fetal 
membranes after 
exposure to progestin 
(17P, P4, and 
medroxyprogesterone 
acetate [MPA]), a 
proinflammatory 
cytokine TNF-a, and 
oxidative stress 
(H2O2). 
 
Progestin, TNF-a, and oxidative stress act as 
regulatory factors of PGRMCI in a cell-specific 
manner in fetal membranes. 
PGRMCI can be regulated by progestins, 
inflammatory cytokines, and oxidative stress in 
the fetal membranes. This study demonstrated 
that inflammation and oxidative stress are 
inseparable in fetal membrane pathology 
Meng et al 
(2016) 
 
Reference #86 
Oxidative stress 
influence on fetal 
membrane senescence 
Experimental 
study  
 
Human fetal 
membranes collected 
following planned 
Hydrogen peroxide significantly induced cell 
senescence and p38 MAPK phosphorylation, and 
it significantly decreased SIRT3 expression in 
This study demonstrated that oxidative stress-
induced cell aging is one of the mechanisms of 
PPROM and PGRMCI acts as a protective 
Feng et al 
(2019) 
Reference #89 
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uncomplicated 
cesarean delivery at 
term without rupture of 
membranes or labor. 
Study aimed to 
investigate the effects 
of oxidative stress 
(represented by 
hydrogen peroxide 
[H2O2] on fetal 
membrane and chorion 
cell senescence, p38 
mitogen-activated 
protein kinase (MAPK) 
phosphorylation, and 
sirtuin (SIRT3) and 
examine the role of 
progesterone  receptor 
membrane component I 
(PGRMCI) in these 
effects 
 
full-thickness fetal membrane explants and 
chorion cells. These effects were enhanced by 
PGRMCI knockdown 
element for maintaining fetal membrane 
integrity by inhibiting oxidative stress-induced 
chorion cell ageing 
Vaginal progesterone 
on the prevention of 
preterm birth  
Systematic review 
and meta-analysis 
of individual 
patient data of 
randomized 
controlled trials 
comparing 
vaginal 
progesterone with 
placebo/no 
treatment in 
women with a 
singleton 
gestation and a 
midtrimester 
sonographic 
cervical length 
≤25 mm 
974 women (498 
assigned to vaginal 
progesterone, 476 
assigned to placebo) 
with a cervical length 
≤25 mm participating 
in five high-quality 
trials 
Vaginal progesterone significantly decreased the 
risk of preterm birth <36, <35, <34, <32, <30 and 
<28 weeks of gestation, spontaneous preterm 
birth <33 and <34 weeks of gestation, respiratory 
distress syndrome, composite neonatal morbidity 
and mortality, birthweight <1500 and <2500 g, 
and admission to the neonatal intensive care uni 
Vaginal progesterone decreases the risk of 
preterm birth and improves perinatal outcomes 
in singleton gestations with a midtrimester 
sonographic short cervix, without any 
demonstrable deleterious effects on childhood 
neurodevelopment 
Romero et al 
(2018) 
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HIGHLIGHTS 
 
• Experimental and clinical evidence correlates oxidative stress to preterm 
delivery regardless of the fetal membrane status.  
• However, it is not known if oxidative stress is a trigger for preterm birth of the 
consequence of infection/inflammation. 
• New biomarkers of oxidative stress and oxidative damage biomarkers using 
mass spectrometry and metabolomics have recently put forward and validated.  
• Hence, the standardization and clinical evaluation of different markers should be 
integrated in the management protocols of preterm birth.  
• Strategies to prevent preterm birth-related oxidative stress should include: 
o preventive antioxidant administration to women with a high-risk for 
preterm birth including 
o administration of appropriate antibiotics with proven microbial invasion 
of the amniotic cavity 
o introduction of anti-inflammatory agents for patients with proven 
inflammation.  
o Appropriate administration of antenatal steroids and magnesium sulfate 
for fetal neuroprotection should be a standard of care in every obstetrical 
unit.  
 
 
